Primaquine

(Primaquine Phosphate)

Primaquine works as an antimalarial medicine by killing malaria parasites that hide in the liver and would otherwise cause relapse. It is effective against the gametocytes of Plasmodium vivax and Plasmodium falciparum malaria, which helps reduce their transmission. It interferes with the parasite’s energy metabolism and generates oxidative stress that the parasite cannot survive.

Follow all directions given to you by your doctor and read all documents provided, including the full Prescribing Information, FDA-Approved Product Labeling, Instructions for Use, and Medication Guide before using Primaquine. However, the following is a synopsis of the general guidelines for the use of Primaquine:

• Primaquine is taken by mouth, usually once daily.
• It is commonly taken with food to reduce stomach pain and nausea.
• The exact dose and length of treatment depend on the type of malaria being treated.
• Primaquine is usually taken for 14 days for the radical cure of vivax malaria.
• Blood testing for glucose-6-phosphate dehydrogenase (G6PD deficiency) is required before treatment.
• Continue taking the medication for the full prescribed course, even if symptoms improve.
• Do not skip doses, as this may increase the risk of malaria relapse.
• If a dose is missed, take it as soon as remembered unless it is close to the next dose.

Some mild or common side effects of Primaquine seen in clinical trials include:

• Stomach pain.
• Nausea.
• Vomiting.
• Abdominal cramps.
• Headache.
• Loss of appetite.

Some individuals may experience serious side effects while using Primaquine. These side effects may require immediate medical attention. If you experience any of the following, contact your healthcare provider or seek emergency medical help:

• Signs of hemolytic anemia include dark urine, pale skin, fatigue, or shortness of breath.
• Yellowing of the skin or eyes.
• Irregular heartbeat or chest discomfort.
• Severe weakness or dizziness.
• Bluish discoloration of lips or skin, which may indicate methemoglobinemia.
• Signs of an allergic reaction include rash, hives, swelling, or trouble breathing.

These are not all of the possible side effects of Primaquine. You should always seek medical advice from your healthcare provider for any questions or concerns about your medical condition or treatment. Read all patient information, medication guides, or drug information sheets that come with this medication. You can also report adverse effects to the Food and Drug Administration at www.fda.gov/medwatch or 1-800-FDA-1088.

Before starting Primaquine, it is crucial to discuss any existing health conditions with your healthcare provider. You should be sure that your healthcare provider is aware of all your medical conditions, including if you have:

• Glucose-6-phosphate dehydrogenase deficiency.
• Nicotinamide adenine dinucleotide (NADH) methemoglobin reductase deficiency.
• A history of hemolytic anemia.
• Lupus erythematosus or rheumatoid arthritis.
• Bone marrow disorders or low blood cell counts.
• Heart rhythm problems.
• Liver disease.
• Kidney disease.
• A history of dark urine or favism.
• Breastfeeding or plans to breastfeed.

Primaquine is contraindicated in patients with glucose-6-phosphate dehydrogenase deficiency due to the risk of severe hemolysis. It should also not be used in patients with known adverse reactions to primaquine or related compounds, as well as those with leukopenia.

Primaquine begins working shortly after starting treatment, but it does not provide immediate symptom relief. Its main role is to eliminate dormant malaria forms in the liver and prevent relapse. Full effectiveness is achieved after completing the entire prescribed course.

When Primaquine is taken with other prescription drugs, over-the-counter medications, vitamins, and supplements, it may change how they work or increase the frequency or severity of side effects. Make sure that you tell your healthcare professional about anything that you are taking to avoid any negative drug interactions, including:

• Chloroquine, which is commonly used alongside Primaquine, may increase gastrointestinal side effects.
• Other drugs that can cause hemolysis or affect red blood cells, increasing the risk of anemia.
• Medications associated with bone marrow suppression, which may raise the risk of low blood cell counts.
• Supplements or drugs that may affect liver function increase the risk of toxicity.

Primaquine is available as oral tablets in standardized dosage forms. The dose is determined by body weight, malaria species, and treatment purpose.

It should be stored at room temperature, away from the reach of children or pets.

Primaquine is manufactured by various pharmaceutical companies and is distributed as a generic prescription drug.

Yes, Primaquine is available as a generic medication.

Do not stop taking Primaquine without speaking to your healthcare provider. Stopping early may increase the risk of malaria relapse. Your provider will advise when treatment is complete.

Primaquine should only be used if the benefits outweigh the risks.

Breastfeeding is not recommended during Primaquine treatment unless the infant has been tested and confirmed not to have glucose-6-phosphate dehydrogenase deficiency. If treatment is necessary, breastfeeding should be avoided for the entire treatment period.